Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Shafer, RW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Kantor, R; Machekano, R; Gonzales, MJ; Dupnik, K; Schapiro, JM; Shafer, RW
      Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs

      NUCLEIC ACIDS RESEARCH
    3. Shulman, N; Zolopa, AR; Passaro, D; Shafer, RW; Huang, W; Katzenstein, D; Israelski, DM; Hellmann, N; Petropoulos, C; Whitcomb, J
      Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy

      AIDS
    4. Smeaton, LM; DeGruttola, V; Robbins, GK; Shafer, RW
      ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1

      CONTROLLED CLINICAL TRIALS
    5. Shafer, RW; Hertogs, K; Zolopa, AR; Warford, A; Bloor, S; Betts, BJ; Merigan, TC; Harrigan, R; Larder, BA
      High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samplesfrom heavily treated patients

      JOURNAL OF CLINICAL MICROBIOLOGY
    6. Gonzales, MJ; Machekano, RN; Shafer, RW
      Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population

      JOURNAL OF INFECTIOUS DISEASES
    7. Shulman, NS; Zolopa, AR; Passaro, DJ; Murlidharan, U; Israelski, DM; Brosgart, CL; Miller, MD; Van Doren, S; Shafer, RW; Katzenstein, DA
      Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: Clinical and genotypic predictors of virologic response

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Shafer, RW; Jung, DR; Betts, BJ
      Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries

      NATURE MEDICINE
    9. Shafer, RW; Deresinski, SC
      Human immunodeficiency virus on the Web: A guided tour

      CLINICAL INFECTIOUS DISEASES
    10. Batra, M; Tien, PC; Shafer, RW; Contag, CH; Katzenstein, DA
      HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    11. Shafer, RW; Jung, DR; Betts, BJ; Xi, YO; Gonzales, MJ
      Human immunodeficiency virus reverse transcriptase and protease sequence database

      NUCLEIC ACIDS RESEARCH
    12. Shafer, RW; Warford, A; Winters, MA; Gonzales, MJ
      Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

      JOURNAL OF VIROLOGICAL METHODS
    13. Demeter, LM; Shafer, RW; Meehan, PM; Holden-Wiltse, J; Fischl, MA; Freimuth, WW; Para, MF; Reichman, RC
      Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    14. Shafer, RW; Chuang, TK; Hsu, P; White, CB; Katzenstein, DA
      Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    15. Shafer, RW; Vuitton, DA
      Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1

      BIOMEDICINE & PHARMACOTHERAPY
    16. Shafer, RW; Stevenson, D; Chan, B
      Human immunodeficiency virus reverse transcriptase and protease sequence database

      NUCLEIC ACIDS RESEARCH
    17. Palmer, S; Shafer, RW; Merigan, TC
      Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development

      AIDS
    18. Palmer, S; Shafer, RW; Merigan, TC
      Hydroxyurea enhances the activities of didanosine, 9-[2(phosphonylmethoxy)ethyl] adenine, and 9-[2(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    19. Shafer, RW; Hsu, P; Patick, AK; Craig, C; Brendel, V
      Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors

      JOURNAL OF VIROLOGY
    20. Zolopa, AR; Shafer, RW; Warford, A; Montoya, JG; Hsu, P; Katzenstein, D; Merigan, TC; Efron, B
      HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

      ANNALS OF INTERNAL MEDICINE
    21. SHAFER RW; KROODSMA K
      AN UPDATE ON THE DIAGNOSIS AND TREATMENT OF HIV, 1998

      Medicamentos de actualidad
    22. WINTERS MA; COOLLEY KL; GIRARD YA; LEVEE DJ; HAMDAN H; SHAFER RW; KATZENSTEIN DA; MERIGAN TC
      A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS

      The Journal of clinical investigation
    23. SHAFER RW; WINTERS MA; PALMER S; MERIGAN TC
      MULTIPLE CONCURRENT REVERSE-TRANSCRIPTASE AND PROTEASE MUTATIONS AND MULTIDRUG-RESISTANCE OF HIV-1 ISOLATES FROM HEAVILY TREATED PATIENTS

      Annals of internal medicine
    24. Shafer, RW; Winters, MA; Palmer, S; Merigan, TC
      Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients (vol 128, pg 906, 1998)

      ANNALS OF INTERNAL MEDICINE
    25. SHAFER RW; LEVEE DJ; WINTERS MA; RICHMOND KL; HUANG D; MERIGAN TC
      COMPARISON OF QIAAMP HCV KIT SPIN COLUMNS, SILICA BEADS, AND PHENOL-CHLOROFORM FOR RECOVERING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM PLASMA

      Journal of clinical microbiology
    26. WINTERS MA; SHAFER RW; JELLINGER RA; MAMTORA G; GINGERAS T; MERIGAN TC
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS

      Antimicrobial agents and chemotherapy
    27. SHAFER RW; EISEN JA; MERIGAN TC; KATZENSTEIN DA
      SEQUENCE AND DRUG SUSCEPTIBILITY OF SUBTYPE-C REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERTERS IN ZIMBABWE

      Journal of virology
    28. JELLINGER RM; SHAFER RW; MERIGAN TC
      A NOVEL-APPROACH TO ASSESSING THE DRUG SUSCEPTIBILITY AND REPLICATIONOF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES

      The Journal of infectious diseases
    29. SHAFER RW; EDLIN BR
      TUBERCULOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS -PERSPECTIVE ON THE PAST DECADE

      Clinical infectious diseases
    30. SHAFER RW; BLOCH AB; LARKIN C; VASUDAVAN V; SELIGMAN S; DEHOVITZ JD; DIFERDINANDO G; STONEBURNER R; CAUTHEN G
      PREDICTORS OF SURVIVAL IN HIV-INFECTED TUBERCULOSIS PATIENTS

      AIDS
    31. SHAFER RW; WINTERS MA; MAYERS DL; JAPOUR AJ; KURITZKES DR; WEISLOW OS; WHITE F; ERICE A; SANNERUD KJ; IVERSEN A; PENA F; DIMITROV D; FRENKEL LM; REICHELDERFER PS
      INTERLABORATORY COMPARISON OF SEQUENCE-SPECIFIC PCR AND LIGASE DETECTION REACTION TO DETECT A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG-RESISTANCE MUTATION

      Journal of clinical microbiology
    32. SHAFER RW; WINTERS MA; IVERSEN AKN; MERIGAN TC
      GENOTYPIC AND PHENOTYPIC CHANGES DURING CULTURE OF A MULTINUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAIN IN THE PRESENCE AND ABSENCE OF ADDITIONAL REVERSE-TRANSCRIPTASE INHIBITORS

      Antimicrobial agents and chemotherapy
    33. IVERSEN AKN; SHAFER RW; WEHRLY K; WINTERS MA; MULLINS JI; CHESEBRO B; MERIGAN TC
      MULTIDRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS RESULTING FROM COMBINATION ANTIRETROVIRAL THERAPY

      Journal of virology
    34. SHAFER RW; WINTERS MA; JELLINGER RM; MERIGAN TC
      ZIDOVUDINE RESISTANCE REVERSE-TRANSCRIPTASE MUTATIONS DURING DIDANOSINE MONOTHERAPY

      The Journal of infectious diseases
    35. KOZAL MJ; SHAFER RW; WINTERS MA; KATZENSTEIN DA; HALPERN J; MERIGAN TC
      THE ASSOCIATION BETWEEN HIV PHENOTYPE, VIRUS BURDEN, CODON-215 MUTATION AND CD4 CELL DECLINE - REPLY

      Journal of acquired immune deficiency syndromes and human retrovirology
    36. DEMETER LM; SHAFER RW; PARA M; MORSE G; FREIMUTH W; MERIGAN TC; REICHMAN RC
      DELAVIRDINE (DLV) SUSCEPTIBILITY OF HIV-1 ISOLATES OBTAINED FROM PATIENTS RECEIVING DLV MONOTHERAPY

      Journal of acquired immune deficiency syndromes and human retrovirology
    37. SHAFER RW; SINGH SP; LARKIN C; SMALL PM
      EXOGENOUS REINFECTION WITH MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS IN AN IMMUNOCOMPETENT PATIENT

      Tubercle and lung disease
    38. SHAFER RW; AGUINIGA E; MERIGAN TC
      QUANTITATIVE-ANALYSIS OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING VIRUS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of clinical microbiology
    39. SHAFER RW; IVERSEN AKN; WINTERS MA; AGUINIGA E; KATZENSTEIN DA; MERIGAN TC
      DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY

      The Journal of infectious diseases
    40. SHAFER RW; MERIGAN TC
      NEW VIROLOGICAL TOOLS FOR THE DESIGN AND ANALYSIS OF CLINICAL-TRIALS

      The Journal of infectious diseases
    41. KOZAL MJ; SHAFER RW; WINTERS MA; KATZENSTEIN DA; MERIGAN TC
      CLARIFICATION OF A METHOD TO REVERSE TRANSCRIBE HUMAN-IMMUNODEFICIENCY-VIRUS RNA

      The Journal of infectious diseases
    42. SHAFER RW; SMALL PM; LARKIN C; SINGH SP; KELLY P; SIERRA MF; SCHOOLNIK G; CHIRGWIN KD
      TEMPORAL TRENDS AND TRANSMISSION PATTERNS DURING THE EMERGENCE OF MULTIDRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY - A MOLECULAR EPIDEMIOLOGIC ASSESSMENT

      The Journal of infectious diseases
    43. KOZAL MJ; SHAFER RW; WINTERS MA; KATZENSTEIN DA; AGUINIGA E; HALPERN J; MERIGAN TC
      HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS

      Journal of acquired immune deficiency syndromes
    44. SHAFER RW; KOZAL MJ; WINTERS MA; IVERSEN AKN; KATZENSTEIN DA; RAGNI MV; MEYER WA; GUPTA P; RASHEED S; COOMBS R; KATZMAN M; FISCUS S; MERIGAN TC
      COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS

      The Journal of infectious diseases
    45. KOZAL MJ; KROODSMA K; WINTERS MA; SHAFER RW; EFRON B; KATZENSTEIN DA; MERIGAN TC
      DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY

      Annals of internal medicine
    46. SMALL PM; SHAFER RW; SCHOOLNIK GK
      REINFECTION WITH MULTIDRUG-RESISTANT TUBERCULOSIS - REPLY

      The New England journal of medicine
    47. SMALL PM; SHAFER RW; HOPEWELL PC; SINGH SP; MURPHY MJ; DESMOND E; SIERRA MF; SCHOOLNIK GK
      EXOGENOUS REINFECTION WITH MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS IN PATIENTS WITH ADVANCED HIV-INFECTION

      The New England journal of medicine
    48. SHAFER RW; LARKIN C; BLOCH AB; DIFERDINANDO G; STONEBURNER R; VASUDAVAN V; COLBY S; MCKINLEY G; DEHOVITZ J; GLADSTONE J; SELIGMAN SJ; CAUTHEN GM
      PREDICTORS OF SURVIVAL IN HIV-SEROPOSITIVE (HIV-DEFINING ILLNESSES() TUBERCULOSIS (TB) PATIENTS (PTS) WITHOUT OTHER AIDS)

      The American review of respiratory disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 19:55:09